Jane Street
TLSIW icon

Jane Street’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Jane Street’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,174
Closed -$20.4K – 10078
2023
Q4 		$20.4K Sell
17,174
-85
-0.5% -$38 ﹤0.01% 8909
2023
Q3 		$6.56K Sell
17,259
-7
-0% -$2 ﹤0.01% 8425
2023
Q2 		$833 Sell
17,266
-18
-0.1% -$1 ﹤0.01% 8558
2023
Q1 		$1.38K Hold
17,284
– – ﹤0.01% 8872
2022
Q4 		$1.3K Hold
17,284
– – ﹤0.01% 8957
2022
Q3 		$1K Hold
17,284
– – ﹤0.01% 9562
2022
Q2 		$1K Sell
17,284
-207
-1% -$40 ﹤0.01% 9506
2022
Q1 		$4K Buy
17,491
+17
+0.1% +$7 ﹤0.01% 10144
2021
Q4 		$9K Buy
17,474
+247
+1% +$227 ﹤0.01% 9915
2021
Q3 		$14K Sell
17,227
-633
-4% -$587 ﹤0.01% 9787
2021
Q2 		$18K Sell
17,860
-740
-4% -$730 ﹤0.01% 9651
2021
Q1 		$20K Buy
+18,600
New +$33.6K ﹤0.01% 8978

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Jane Street's TLSIW Position: Q1 2024 in Review

Jane Street sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2024, closing a stake of 17,174 shares — an estimated $20.4K sold.

Jane Street first reported a position in TLSIW in Q1 2021 and held it in 12 quarters. The position peaked at $20.4K in Q4 2023. 21 funds tracked by Wall St. Rank hold TLSIW as of Q1 2024.

  • Jane Street reported no remaining TriSalus Life Sciences Warrant position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 17,174 TriSalus Life Sciences Warrant shares in Q1 2024, an estimated $20.4K.
  • Jane Street first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 12 quarters.
  • Jane Street's TriSalus Life Sciences Warrant position peaked at $20.4K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.